Biological Products, (No Diagnostic Substances)·WALTHAM, MA
Financials
20 shown
Type
Period
Ended
Filed
10-K
FY 2025
12/31/25
2/26/26
→
10-Q
Q3 2025
9/30/25
11/4/25
→
10-Q
Q2 2025
6/30/25
8/7/25
→
10-Q
Q1 2025
3/31/25
4/29/25
→
10-K
FY 2024
12/31/24
3/14/25
→
10-Q
Q3 2024
9/30/24
11/18/24
→
↓
Earnings Releases (8-K)
37 shown
Filed
Period
2/24/26
Q1 FY2026
→
10/28/25
Q3 FY2025
→
7/29/25
Q2 FY2025
→
4/29/25
Q1 FY2025
→
2/20/25
Q1 FY2025
→
11/12/24
Q4 FY2024
→
↓
News (8-K)
43 shown
Filed
Type
Description
1/6/26
Exec Change
Departure or Appointment of Directors or Certain Officers
→
9/2/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
5/15/25
Vote
Amendments to Articles of Incorporation or Bylaws
→
7/15/24
Other
Other Events
→
6/14/24
Exec Change
Departure or Appointment of Directors or Certain Officers
→
6/13/24
Reg FD
Regulation FD Disclosure
→
↓
Prospectuses & Registrations
28 shown
Filed
Form
Description
4/4/25
ARS
ARS
→
4/1/24
ARS
ARS
→
4/11/23
ARS
ARS
→
11/5/21
424B7
424B7
→
12/8/20
424B5
424B5
→
12/7/20
424B5
424B5
→
↓
Filing History(1000 filings)
TypeDateAccessionPeriodSize
4
Mar 5, 2026
0001193125-26-0933794
Mar 4, 2026
6.3 KB
4
Mar 5, 2026
0001193125-26-0933684
Mar 4, 2026
6.3 KB
4
Mar 3, 2026
0001193125-26-0876694
Feb 27, 2026
6.0 KB
4
Mar 3, 2026
0001193125-26-0875954
Feb 27, 2026
6.0 KB
4
Mar 3, 2026
0001193125-26-0875914
Mar 2, 2026
4.5 KB
4
Mar 3, 2026
0001193125-26-0875794
Feb 27, 2026
5.9 KB
4
Mar 3, 2026
0001193125-26-0875684
Feb 27, 2026
5.9 KB
4
Mar 3, 2026
0001193125-26-0874474
Mar 2, 2026
4.6 KB
10-K
Feb 26, 2026
0001193125-26-07652810-K
Dec 31, 2025
22.6 MB
8-K
Feb 24, 2026
0001193125-26-0652468-K
Feb 24, 2026
1.4 MB
SCHEDULE 13G/A
Feb 17, 2026
0000080255-26-000253
—
7.5 KB
SCHEDULE 13G/A
Feb 13, 2026
0001213900-26-016380
—
10.9 KB
SCHEDULE 13G
Feb 5, 2026
0000315066-26-000516
—
11.1 KB
4
Jan 12, 2026
0001193125-26-0104704
Dec 31, 2025
7.0 KB
3
Jan 12, 2026
0001193125-26-0104633
Dec 31, 2025
22.0 KB
8-K
Jan 6, 2026
0001193125-26-0034678-K
Jan 6, 2026
174.3 KB
4
Dec 18, 2025
0001193125-25-3249124
Dec 17, 2025
4.2 KB
4
Dec 17, 2025
0001193125-25-3228214
Dec 16, 2025
6.3 KB
144
Dec 17, 2025
0001959173-25-007821
—
4.2 KB
4
Dec 8, 2025
0001193125-25-3112904
Dec 4, 2025
4.5 KB
4
Nov 26, 2025
0001193125-25-3006424
Nov 25, 2025
4.5 KB
144
Nov 25, 2025
0001959173-25-007258
—
6.0 KB
4
Nov 19, 2025
0001193125-25-2881604
Nov 18, 2025
4.8 KB
144
Nov 18, 2025
0001959173-25-007117
—
4.8 KB
4
Nov 14, 2025
0001193125-25-2830924
Nov 13, 2025
19.1 KB
25 filings shown
REPLIGEN CORP — SlamSEC
Proxies
29 shown
Filed
Form
Description
4/4/25
DEFA14A
DEFA14A
→
4/4/25
DEF 14A
DEF 14A
→
3/17/25
PRE 14A
PRE 14A
→
5/3/24
DEFA14A
DEFA14A
→
4/1/24
DEFA14A
DEFA14A
→
4/1/24
DEF 14A
DEF 14A
→
↓
Ownership
40 shown
Filed
Form
Description
3/5/26
4
4
→
3/5/26
4
4
→
3/3/26
4
4
→
3/3/26
4
4
→
3/3/26
4
4
→
3/3/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/13/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/5/26
SCHEDULE 13G
SCHEDULE 13G
→
12/17/25
144
144
→
11/25/25
144
144
→
11/18/25
144
144
→
↓
2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN.